Guaranteed Issue

Guaranteed Issue is a provision in insurance that guarantees an applicant's acceptance into a health insurance plan regardless of their health status or medical history. In other words, the insurer cannot deny coverage to an individual based on pre-existing conditions, current health status, or other risk factors.

Key features of Guaranteed Issue include:

• No medical underwriting: Insurance companies are required to accept all applicants who meet the eligibility criteria without requiring them to complete a medical questionnaire or undergo a medical examination.

• No exclusions for pre-existing conditions: Insurance companies cannot exclude coverage or charge higher premiums based on an applicant's pre-existing medical conditions.

• Guaranteed acceptance: Eligible applicants must be accepted into the plan regardless of their health status, age, gender, or other factors.

An example of Guaranteed Issue would be the provision under the Affordable Care Act (ACA) that requires health insurers to accept all applicants during the annual open enrollment period without considering their health status or pre-existing medical conditions. The provision applies to both individual and group health insurance plans. Additionally, some states have enacted laws that require guaranteed issue for specific types of insurance coverage, such as disability insurance or long-term care insurance.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.